LNA Sante SA is engaged in the management and operation of retirement homes, nursing homes, follow-up care clinics, rehabilitation centers, centers for the disabled and handicapped ageing.
1990
3.3K+
LTM Revenue $888M
LTM EBITDA $165M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
LNA Sante has a last 12-month revenue of $888M and a last 12-month EBITDA of $165M.
In the most recent fiscal year, LNA Sante achieved revenue of $791M and an EBITDA of $156M.
LNA Sante expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See LNA Sante valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $782M | $791M | XXX | XXX | XXX |
Gross Profit | $621M | $669M | XXX | XXX | XXX |
Gross Margin | 79% | 85% | XXX | XXX | XXX |
EBITDA | $160M | $156M | XXX | XXX | XXX |
EBITDA Margin | 20% | 20% | XXX | XXX | XXX |
Net Profit | $25.3M | $27.7M | XXX | XXX | XXX |
Net Margin | 3% | 4% | XXX | XXX | XXX |
Net Debt | $385M | $359M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, LNA Sante's stock price is EUR 23 (or $24).
LNA Sante has current market cap of EUR 232M (or $249M), and EV of EUR 1.0B (or $1.1B).
See LNA Sante trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$1.1B | $249M | XXX | XXX | XXX | XXX | $2.42 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, LNA Sante has market cap of $249M and EV of $1.1B.
LNA Sante's trades at 1.2x LTM EV/Revenue multiple, and 6.7x LTM EBITDA.
Analysts estimate LNA Sante's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for LNA Sante and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $1.1B | XXX | XXX | XXX |
EV/Revenue | 1.4x | XXX | XXX | XXX |
EV/EBITDA | 7.1x | XXX | XXX | XXX |
P/E | 9.9x | XXX | XXX | XXX |
P/E/Growth | 0.5x | XXX | XXX | XXX |
EV/FCF | 12.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpLNA Sante's NTM/LTM revenue growth is 9%
LNA Sante's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, LNA Sante's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate LNA Sante's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for LNA Sante and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 1% | XXX | XXX | XXX | XXX |
EBITDA Margin | 20% | XXX | XXX | XXX | XXX |
EBITDA Growth | -2% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 29% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 12% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 81% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
LNA Sante acquired XXX companies to date.
Last acquisition by LNA Sante was XXXXXXXX, XXXXX XXXXX XXXXXX . LNA Sante acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was LNA Sante founded? | LNA Sante was founded in 1990. |
Where is LNA Sante headquartered? | LNA Sante is headquartered in France. |
How many employees does LNA Sante have? | As of today, LNA Sante has 3.3K+ employees. |
Who is the CEO of LNA Sante? | LNA Sante's CEO is Mr. Willy Siret. |
Is LNA Sante publicy listed? | Yes, LNA Sante is a public company listed on PAR. |
What is the stock symbol of LNA Sante? | LNA Sante trades under LNA ticker. |
When did LNA Sante go public? | LNA Sante went public in 2006. |
Who are competitors of LNA Sante? | Similar companies to LNA Sante include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
What is the current market cap of LNA Sante? | LNA Sante's current market cap is $249M |
What is the current revenue of LNA Sante? | LNA Sante's last 12-month revenue is $888M. |
What is the current EBITDA of LNA Sante? | LNA Sante's last 12-month EBITDA is $165M. |
What is the current EV/Revenue multiple of LNA Sante? | Current revenue multiple of LNA Sante is 1.2x. |
What is the current EV/EBITDA multiple of LNA Sante? | Current EBITDA multiple of LNA Sante is 6.7x. |
What is the current revenue growth of LNA Sante? | LNA Sante revenue growth between 2023 and 2024 was 1%. |
Is LNA Sante profitable? | Yes, LNA Sante is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.